Literature DB >> 168146

Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

G Utermann, H J Menzel, K H Langer, P Dieker.   

Abstract

The lipoproteins from two sibs with familial lecithin-cholesterol-acyltransferase(LCAT)-deficiency were further characterized. Comparatively lipoproteins from patients with secondary LCAT-deficiency were studied. Both groups of patients had particles of unusual size and shape in the alpha1-(HD-2)-lipoprotein subfraction. The abnormal HDL-2 particles were disk-like in appearance with a major axis of about 180 A and a minor axis of about 40 A and tended to aggregate into long coinlike stacks. The abnormal HDL-2 particles contained the normal protein constituents of HDL Apo A-I, Apo A-II and Apo C but in addition a major polypeptide with a M.W. of 39000 not seen in significant amounts in normal high-density-lipoproteins. This polypeptide was found identical in size, isoelectric focusing and immunochemically with an arginine-rich normal polypeptide constituent of very-low-density-lipoproteins designated apoprotein E. Presence of this protein marker in the HDL allowed the specific immunological detection of the abnormal HDL-2 (LP-E) in plasma. Further minor biochemical abnormalities were observed in the lipoproteins of the patients with familial LCAT-deficiency. However, the main protein constituents of their HDL, the Apo A, Apo C and Apo E polypeptides, were found to be identical electrophoretically and by analytical isoelectric focusing with their normal counterparts. The data suggest that the basic genetic defect in the hereditary disease leads to a deficient activity of the LCAT-enzyme and that all abnormalities in the lipoprotein spectrum are secondary.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168146     DOI: 10.1007/bf00278345

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


  26 in total

1.  Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:Cholesterol acyltransferase deficiency.

Authors:  Harald Torsvik; Kåre Berg; Harry N. Magnani; Walter J. McConathy; Peter Alaupovic; Egil Gjone
Journal:  FEBS Lett       Date:  1972-08-01       Impact factor: 4.124

2.  An apolipoprotein preferentially enriched in cholesteryl ester-rich very low density lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochem Biophys Res Commun       Date:  1974-05-07       Impact factor: 3.575

3.  Identification of lipoprotein families in familial lecithin: cholesterol acyltransferase deficiency.

Authors:  W J McConathy; P Alaupovic; M D Curry; H N Magnani; H Torsvik; K Berg; E Gjone
Journal:  Biochim Biophys Acta       Date:  1973-12-20

4.  Studies on the protein moiety of serum high density lipoprotein from patients with familial lecithin: cholesterol acyltransferase deficiency.

Authors:  H Torsvik
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

5.  Editorial: Familial LCAT deficiency.

Authors:  E Gjone
Journal:  Acta Med Scand       Date:  1973-11

6.  Lipoproteins in LCAT-deficiency.

Authors:  G Utermann; W Schoenborn; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1972

7.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins.

Authors:  K R Norum; J A Glomset; A V Nichols; T Forte
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

8.  Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.

Authors:  R J Havel; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

9.  A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.

Authors:  D Seidel; P Alaupovic; R H Furman; W J McConathy
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

Authors:  D Seidel; P Alaupovic; R H Furman
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

View more
  4 in total

1.  Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

Authors:  G Assmann; P N Herbert; D S Fredrickson; T Forte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Authors:  D J Rader; K Ikewaki; N Duverger; H Schmidt; H Pritchard; J Frohlich; M Clerc; M F Dumon; T Fairwell; L Zech
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

3.  Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver.

Authors:  R L Hamilton; M C Williams; C J Fielding; R J Havel
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

4.  Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice.

Authors:  G M Kostner; P Laggner; H J Prexl; A Holasek
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.